Joshua Reed
CIK 1746541 · SVP, Chief Financial Officer · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.51M
Companies
4
Total Filings
23
Lifetime Open-Market Net
-$309.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Director | 20,466 | $52.64 | $1.08M | -$324.5K | 8 | 2026-07-06 |
| ALKS | SVP, Chief Financial Officer | — | $48.37 | — | $0 | 2 | 2026-03-04 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Chief Financial Officer | — | $0.14 | — | $0 | 4 | 2024-02-09 |
| ALDX | Chief Financial Officer | 274,825 | $1.59 | $437.0K | $15.1K | 7 | 2022-04-01 |
Recent Filings · Page 2 of 3
23 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-22 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-28 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-02 | Omega Therapeutics, Inc. (OMGA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2022-04-01 | ALDX | Grant (A) | +93,322 | $0 | EDGAR |
| 2021-04-14 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2021-03-18 | SRRK | Grant (A) | — | $0 | EDGAR |
| 2020-03-06 | ALDX | Grant (A) | +137,707 | $0 | EDGAR |
| 2020-03-04 | ALDX | Grant (A) | +250,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.